Eli Lilly draws the line on DTC

Eli Lilly is drawing the line on DTC—at the spots plugging the services of ambulance-chasing trial lawyers. The company surveyed 402 shrinks and found that ads by would-be litigators warning of side effects in anti-psychotics are scaring patients off the drugs.

Next Article in Pharmaceutical